Cargando…

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

BACKGROUND: In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To address this gap, we initiated an ongoing prospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hayang, Bouma, Berto J., Mulder, Barbara J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591797/ https://www.ncbi.nlm.nih.gov/pubmed/28785894 http://dx.doi.org/10.1007/s10557-017-6745-y

Ejemplares similares

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

An implantable loop recorder or smartphone based single-lead electrocardiogram to detect arrhythmia in adults with congenital heart disease?
por: Koole, Maarten A., et al.
Publicado: (2023)

Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
por: Schuuring, Mark J, et al.
Publicado: (2010)

Secundum atrial septal defect in adults: a practical review and recent developments
por: Kuijpers, Joey M., et al.
Publicado: (2015)

The effects of curcumin on the prevention of atrial and ventricular arrhythmias and heart failure in patients with unstable angina: A randomized clinical trial
por: Dastani, Mostafa, et al.
Publicado: (2019)

Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe
por: Yang, Hayang, et al.
Publicado: (2019)

Arrhythmias in adults with congenital heart disease and heart failure
por: Bessière, Francis, et al.
Publicado: (2021)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
por: He, Qiyu, et al.
Publicado: (2019)

New developments in adult congenital heart disease
por: Bouma, B. J., et al.
Publicado: (2020)

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic
por: de Veer, A. J. W. M., et al.
Publicado: (2019)

Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014)

TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022)

Outcomes of Atrial Arrhythmia Surgery in Patients With Congenital Heart Disease: A Systematic Review
por: Houck, Charlotte A., et al.
Publicado: (2020)

Type D Personality Associated With Increased Risk for Mortality in Adults With Congenital Heart Disease
por: Kauw, Dirkjan, et al.
Publicado: (2022)

The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias
por: Kartas, Anastasios, et al.
Publicado: (2022)

Association of Health Status Metrics with Clinical Outcomes in Patients with Adult Congenital Heart Disease and Atrial Arrhythmias
por: Baroutidou, Amalia, et al.
Publicado: (2022)

Heart Murmur in Neonates: How Often Is It Caused by Congenital Heart Disease?
por: Mirzarahimi, Mehrdad, et al.
Publicado: (2011)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality
por: Woudstra, Odilia I, et al.
Publicado: (2019)

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018)

Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement
por: Wu, Victor Chien-Chia, et al.
Publicado: (2020)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
por: Melgaard, Line, et al.
Publicado: (2021)

Atrial Arrhythmia Ablation in Adult Congenital Heart Disease with a Persistent Left-side Superior Vena Cava
por: Yamada, Shinya, et al.
Publicado: (2017)

Right ventricular function declines after cardiac surgery in adult patients with congenital heart disease
por: Schuuring, Mark J., et al.
Publicado: (2011)

Cardiac Arrhythmias In Congenital Heart Diseases
por: Khairy, Paul, et al.
Publicado: (2009)

Age, left atrial dimension and arterial stiffness after external cardioversion of atrial fibrillation. A vascular component in arrhythmia maintenance? Results from a preliminary study
por: Fumagalli, Stefano, et al.
Publicado: (2013)

Are NOACs as safe and efficient as VKA regarding thromboembolic prophylaxis and major bleeding in patients with surgical bioprosthesis and atrial fibrillation within 3 months of surgery?
por: Magro, Pedro Lamares, et al.
Publicado: (2022)

Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease
por: van Dissel, Alexandra C., et al.
Publicado: (2018)

Diagnostic dilemma in a child with congenital heart disease on sildenafil
por: Zaki, Syed Ahmed, et al.
Publicado: (2009)

Adults with congenital heart disease: ready for mobile health?
por: Treskes, R. W., et al.
Publicado: (2019)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Publicado: (2020)

Reversal agents for NOACs: Connecting the dots
por: Dalal, Jamshed, et al.
Publicado: (2016)

What is important in family counseling in cases of fetuses with congenital heart disease?
por: Dias, Marcela Bezerra, et al.
Publicado: (2023)

Transcatheter ablation of arrhythmias associated with congenital heart disease
por: Szili-Torok, Tamas, et al.
Publicado: (2008)

Prepregnancy exposure to dietary arsenic and congenital heart defects
por: Suhl, Jonathan, et al.
Publicado: (2022)

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials
por: Noseworthy, Peter A., et al.
Publicado: (2017)

Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
por: Milojevic, Milan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4h26tp7ro2lvt00k4avcddtd60